Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$118.41 +3.7%	$111.97	$88.96 ▼ $136.72	$2.18B	0.8	201,103 shs	133,138 shs
CELC Celcuity	$52.42 +4.0%	$26.23	$7.57 ▼ $53.85	$2.22B	0.68	3.03 million shs	956,376 shs
CSTL Castle Biosciences	$20.84 +4.4%	$18.74	$14.59 ▼ $35.84	$604.53M	1.09	698,846 shs	354,984 shs
LFST LifeStance Health Group	$5.55 +0.9%	$4.67	$3.74 ▼ $8.61	$2.16B	1.13	3.18 million shs	3.28 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	0.00%	+2.87%	+9.48%	+5.57%	-10.60%
CELC Celcuity	0.00%	+1.22%	+273.10%	+402.11%	+208.53%
CSTL Castle Biosciences	0.00%	+3.73%	+26.84%	+29.44%	-25.17%
LFST LifeStance Health Group	0.00%	+2.02%	+34.06%	+1.09%	-3.98%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADUS Addus HomeCare	4.9217 of 5 stars	3.5	3.0	5.0	3.3	2.5	3.1
CELC Celcuity	1.1328 of 5 stars	1.5	2.0	0.0	2.9	3.3	0.0
CSTL Castle Biosciences	2.5485 of 5 stars	3.5	3.0	0.0	2.9	1.7	0.0
LFST LifeStance Health Group	3.1717 of 5 stars	3.4	4.0	0.0	2.3	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	3.00	Buy	$138.38	16.86% Upside
CELC Celcuity	3.00	Buy	$50.60	-3.47% Downside
CSTL Castle Biosciences	3.00	Buy	$37.00	77.54% Upside
LFST LifeStance Health Group	2.86	Moderate Buy	$8.50	53.15% Upside

Current Analyst Ratings Breakdown

Latest CSTL, ADUS, LFST, and CELC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/22/2025	ADUS Addus HomeCare	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$133.00 ➝ $134.00
8/19/2025	ADUS Addus HomeCare	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$83.00 ➝ $109.00
8/18/2025	CELC Celcuity	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$50.00 ➝ $66.00
8/15/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$74.00 ➝ $70.00
8/8/2025	LFST LifeStance Health Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.50 ➝ $9.00
8/6/2025	ADUS Addus HomeCare	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$135.00 ➝ $139.00
7/28/2025	CELC Celcuity	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$28.00 ➝ $60.00
7/28/2025	CELC Celcuity	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$27.00 ➝ $50.00
7/28/2025	CELC Celcuity	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$29.00
7/25/2025	LFST LifeStance Health Group	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$8.00
7/16/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.15B	1.89	$5.39 per share	21.97	$55.51 per share	2.13
CELC Celcuity	N/A	N/A	N/A	N/A	$1.05 per share	N/A
CSTL Castle Biosciences	$332.07M	1.82	$0.98 per share	21.18	$15.70 per share	1.33
LFST LifeStance Health Group	$1.25B	1.73	$0.04 per share	139.96	$3.79 per share	1.46

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$73.60M	$4.53	26.14	22.09	1.80	6.51%	9.39%	6.86%	11/3/2025 (Estimated)
CELC Celcuity	-$111.78M	-$3.45	N/A	N/A	N/A	N/A	-150.07%	-64.67%	N/A
CSTL Castle Biosciences	$18.25M	-$0.35	N/A	N/A	N/A	-2.73%	2.37%	2.03%	11/3/2025 (Estimated)
LFST LifeStance Health Group	-$57.44M	-$0.05	N/A	N/A	N/A	-1.23%	-1.11%	-0.76%	11/6/2025 (Estimated)

Latest CSTL, ADUS, LFST, and CELC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	CELC Celcuity	-$0.90	-$1.04	-$0.14	-$1.04	N/A	N/A
8/7/2025	Q2 2025	LFST LifeStance Health Group	-$0.03	-$0.01	+$0.02	-$0.01	$345.05 million	$345.31 million
8/4/2025	Q2 2025	ADUS Addus HomeCare	$1.45	$1.49	+$0.04	$1.20	$345.71 million	$349.44 million
8/4/2025	Q2 2025	CSTL Castle Biosciences	-$0.51	$0.15	+$0.66	$0.15	$71.53 million	$86.18 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
CELC Celcuity	N/A	N/A	N/A	N/A	N/A
CSTL Castle Biosciences	N/A	N/A	N/A	N/A	N/A
LFST LifeStance Health Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.17	1.74	1.74
CELC Celcuity	2.24	4.58	6.61
CSTL Castle Biosciences	0.02	6.85	6.69
LFST LifeStance Health Group	0.19	1.48	1.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
CELC Celcuity	63.33%
CSTL Castle Biosciences	92.60%
LFST LifeStance Health Group	85.50%

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.50%
CELC Celcuity	15.77%
CSTL Castle Biosciences	6.50%
LFST LifeStance Health Group	3.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	49,703	18.41 million	17.58 million	Optionable
CELC Celcuity	40	42.43 million	35.74 million	Optionable
CSTL Castle Biosciences	540	29.01 million	27.12 million	Optionable
LFST LifeStance Health Group	10,218	388.94 million	376.49 million	Optionable

CSTL, ADUS, LFST, and CELC Headlines

Recent News About These Companies

Sarah Personette Joins Lifestance Health Board

August 22 at 10:17 PM | msn.com

Sarah Personette Appointed to LifeStance Board of Directors

August 22 at 9:00 AM | prnewswire.com

EntryPoint Capital LLC Buys 55,382 Shares of LifeStance Health Group, Inc. $LFST

August 22 at 5:57 AM | marketbeat.com

Insider Selling: LifeStance Health Group (NASDAQ:LFST) Major Shareholder Sells 3,592,357 Shares of Stock

August 21 at 7:28 AM | insidertrades.com

Versor Investments LP Boosts Stake in LifeStance Health Group, Inc. $LFST

August 20, 2025 | marketbeat.com

LifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician Expansion

August 18, 2025 | finance.yahoo.com

LifeStance Health Group (NASDAQ:LFST) Trading 4.5% Higher - Here's Why

August 16, 2025 | marketbeat.com

LifeStance Health Group (NASDAQ:LFST) Shares Gap Up - Should You Buy?

August 15, 2025 | marketbeat.com

LifeStance (LFST) Extends 4-Day Run on Strong Earnings

August 14, 2025 | finance.yahoo.com

LifeStance Health’s Earnings Call Highlights Robust Growth

August 13, 2025 | msn.com

LifeStance Health Group (NASDAQ:LFST) Raised to Buy at Wall Street Zen

August 10, 2025 | marketbeat.com

UBS Group Raises LifeStance Health Group (NASDAQ:LFST) Price Target to $9.00

August 9, 2025 | marketbeat.com

LifeStance Health Group (NASDAQ:LFST) Trading Up 9.4% on Earnings Beat

August 9, 2025 | marketbeat.com

What is William Blair's Estimate for LFST Q1 Earnings?

August 9, 2025 | marketbeat.com

Why LifeStance Health Group (LFST) Stock Is Up Today

August 9, 2025 | msn.com

LifeStance Health Group, Inc. (LFST) Q2 2025 Earnings Call Transcript

August 8, 2025 | seekingalpha.com

LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2025 | zacks.com

LifeStance Reports Second Quarter 2025 Results

August 7, 2025 | globenewswire.com

LifeStance Health Group (LFST) Reports Earnings Tomorrow: What To Expect

August 6, 2025 | msn.com

LifeStance Health Group, Inc. (NASDAQ:LFST) Given Consensus Rating of "Moderate Buy" by Analysts

August 6, 2025 | marketbeat.com

Mackenzie Financial Corp Invests $1.34 Million in LifeStance Health Group, Inc. (NASDAQ:LFST)

August 5, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CSTL, ADUS, LFST, and CELC Company Descriptions

Addus HomeCare NASDAQ:ADUS

$118.41 +4.23 (+3.70%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$118.41 0.00 (0.00%)

As of 08/22/2025 05:12 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Celcuity NASDAQ:CELC

$52.42 +2.04 (+4.05%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$51.58 -0.84 (-1.61%)

As of 08/22/2025 07:37 PM Eastern

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Castle Biosciences NASDAQ:CSTL

$20.84 +0.87 (+4.36%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$20.60 -0.24 (-1.15%)

As of 08/22/2025 05:10 PM Eastern

Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

LifeStance Health Group NASDAQ:LFST

$5.55 +0.05 (+0.91%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$5.45 -0.10 (-1.80%)

As of 08/22/2025 05:06 PM Eastern

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time